Improving human capital and implementation of the institutional Policy of the National Vaccine Institute, Ghana

The funding opportunity titled "Improving human capital and implementation of the institutional Policy of the National Vaccine Institute, Ghana," aims to support the National Vaccine Institute of Ghana with a total budget of €1,200,000. This grant falls under the EuropeAid identifier EuropeAid/184869/DD/ACT/GH and is currently active with a deadline for proposals set for September 30, 2025. It specifically targets Ghana as its geographical zone and is part of the broader EU cooperation effort in Africa, particularly in health sector development.

Eligible applicants for this grant are primarily the National Vaccine Institute of Ghana, categorized as a government institution dedicated to coordinating vaccine production and distribution. The funding type is classified as an Action Grant, which is intended to provide non-repayable financial support for capacity-building initiatives rather than commercial activities.

A consortium is required for this grant as it operates on a "Twinning" model, necessitating partnerships between Ghana's National Vaccine Institute and public institutions from EU member states. The main focus of the project is on enhancing human capital and implementing institutional policies, specifically in the health sector that involves vaccine research and development.

The application process for this opportunity is structured as an open call, and applicants are encouraged to refer to available documents such as the Twinning Fiche, Logical Framework, and Publication Notice for complete details on application procedures, eligibility criteria, and project requirements.

The project is situated at an institutional development stage, aimed at improving the capabilities of the National Vaccine Institute as a foundational step toward future vaccine production. The financial support will address areas such as organizational capacity building, policy implementation frameworks, and workforce training in line with Ghana's national vaccine roadmap.

Overall, this grant is part of the EU's initiative to enhance vaccine production capabilities within Africa, aligning with the vision of achieving 60% local vaccine production by 2040. Interested stakeholders should prepare to apply before the specified deadline, ensuring compliance with the requirements laid out in the respective documents.

The funding opportunity is titled "Improving human capital and implementation of the institutional Policy of the National Vaccine Institute, Ghana." The reference number for this opportunity is EuropeAid/184869/DD/ACT/GHSedia.global.openforsubmissionGrantInternal navigationGeneral informationDocumentsSubmission serviceGeneral information.

The program under which this funding is offered is Sub-Saharan Africa. The geographical zone for this opportunity is Ghana.

The total budget allocated for this action is 1,200,000 EUR (one million two hundred thousand euros).

The type of grant is Action Grants.

The publication date of this opportunity was July 23, 2025. The opportunity was last updated on July 23, 2025.

The deadline for submitting proposals is September 30, 2025.

The following documents are available for download: Twinning Fiche- Ghana (dated July 23, 2025, in English), Logical Framework (dated July 23, 2025, in English), and Publication Notice - Ghana (dated July 23, 2025, in English).

In summary, this is an Action Grant opportunity focused on improving human capital and implementing the institutional policy of the National Vaccine Institute in Ghana. It falls under the Sub-Saharan Africa program with a budget of 1,200,000 EUR. The deadline for applications is September 30, 2025. Interested applicants should review the provided documents, including the Twinning Fiche, Logical Framework, and Publication Notice, for detailed information and application guidelines.

Eligible Applicant Types: The provided text does not explicitly list eligible applicant types. However, given the focus on improving human capital and institutional policy at the National Vaccine Institute in Ghana, it is highly likely that eligible applicants would include research institutes, universities, governmental organizations, NGOs, and potentially public-private partnerships with a focus on vaccine research, public health, and institutional capacity building. The reference to "Twinning Fiche" suggests that collaborations with European institutions may be favored or required.

Funding Type: The funding type is explicitly stated as "Action Grants."

Consortium Requirement: The text mentions a "Twinning Fiche," which strongly suggests that a consortium, or at least a partnership, is required, likely involving a European institution twinned with the National Vaccine Institute of Ghana. Therefore, a consortium is very likely to be required.

Beneficiary Scope (Geographic Eligibility): The primary beneficiary scope is Ghana, as the project focuses on the National Vaccine Institute in Ghana. However, given the likely requirement for a "Twinning" arrangement, European institutions are also implicitly eligible as partners. Therefore, the geographic eligibility includes Ghana and likely extends to the EU or specific European countries participating in the twinning program.

Target Sector: The target sector is clearly health, specifically vaccine research and development, public health, and institutional capacity building within the context of a national vaccine institute. It also touches upon institutional policy and human capital development.

Mentioned Countries: Ghana is explicitly mentioned. The reference to the "Twinning Fiche" implies the involvement of at least one EU member state, though no specific country is named. Therefore, Ghana and the EU are relevant.

Project Stage: The project stage is not explicitly stated. However, given the focus on improving human capital and implementing institutional policy, it suggests a project stage that is beyond basic research and more towards development, implementation, and capacity building. It could encompass elements of validation and demonstration within the Ghanaian context.

Funding Amount: The budget is explicitly stated as 1,200,000 EUR (1.2 million EUR).

Application Type: The application type is not explicitly stated, but the presence of a "Submission service" and the phrase "openforsubmissionGrant" suggests an open call.

Nature of Support: The "Action Grant" funding type indicates that beneficiaries will receive money.

Application Stages: The number of application stages cannot be determined from the provided text. It would require reviewing the "Publication Notice" or the submission portal for details.

Success Rates: The success rates cannot be determined from the provided text.

Co-funding Requirement: The co-funding requirement cannot be determined from the provided text. The "Publication Notice" or other documentation would need to be reviewed.

Summary:

This opportunity is an Action Grant funded by the European Union, with a budget of 1.2 million EUR, aimed at improving human capital and implementing the institutional policy of the National Vaccine Institute in Ghana. The deadline for applications is September 30, 2025. The program falls under the Sub-Saharan Africa geographical zone, specifically targeting Ghana. The grant likely requires a consortium or partnership, potentially through a "twinning" arrangement with a European institution. The target sector is health, with a focus on vaccine research and development, public health initiatives, and strengthening the institutional capacity of the National Vaccine Institute. The project likely involves development, implementation, and capacity-building activities. Applicants should review the "Publication Notice," "Logical Framework," and "Twinning Fiche" documents for detailed information on eligibility criteria, application procedures, and project requirements. The presence of a "Submission service" suggests an open call for proposals. The grant aims to support Ghana's National Vaccine Institute in enhancing its capabilities and policies related to vaccine development and public health.